Floatz logo

Tenecteplase

Cognitive Impairment

Pennington Biomedical Research Centerprotein_peptideN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
81/ 100

Competitive context

22 Active assets in the Cognitive Impairment cohort.

Asset / SponsorPhaseRating
Rivastigmine
VA Office of Research and Development
Phase 4BB
Egb 761®
Ipsen
Phase 4BB
Namenda
UNC Lineberger Comprehensive Cancer Center
Phase 3BB
Pioglitazone
University of Colorado, Denver
Phase 4BB
Choline Alfoscerate
Chong Kun Dang Pharmaceutical
Phase 4BB

View all 50 →

Same molecule, other indications

Tenecteplase is also rated in:

basilar artery occlusionDormant
BBB
Indicative ·
75 / 100
View asset →
ischemic strokeDormant
BBB
Indicative ·
72 / 100
View asset →
stroke disorderDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →